Extracorporeal Shock Wave Therapy on Osteoblast-Like Cells In- Vitro Study (ESWT)

Krishnadevaraya College of Dental Sciences & Hospital

Status: Completed

Conditions: Osteosarcoma

Treatments: Device: Extracorporeal shockwave device; Device: No ESWT

Study type: Interventional

Funder types: Other

Identifiers

NCT05801887

02_D012_112292

Details and patient eligibility

About

The idea of treating different deformities or diseases in the maxillofacial region with Extracorporeal Shockwave Therapy (ESWT) has recently become popular. It has been widely used in medical practice for the management of urolithiasis, cholelithiasis and in haead and neck region for sialolithiasis. The present study 'Extracorporeal Shock Wave Therapy on Osteoblast-Like Cells In-vitro study' will be done to explore and evaluate the effect of shockwaves. Further, Osteoblast-like cells will be assessed for Cell - Cell interaction and Cell Viability. It will be assessed using a scratch assay, Mtt assay and ATP analysis.

Full description

Introduction:

Extracorporeal Shockwave Therapy (ESWT) has recently become popular. Shockwave has been widely used in medical practice for the management of urolithiasis, cholelithiasis and in haead and neck region for sialolithiasis.

Aim:

This study 'Extracorporeal Shock Wave Therapy on Osteoblast-Like Cells In-vitro study' will be done to explore and evaluate the effect of shockwaves. Further, Osteoblast-like cells will be assessed for Cell - Cell interaction and Cell Viability.

Methodology:

In this in-vitro study, 20 Osteoblast - like cells will be included. 10 samples to be considered for Control group and the remaining 10 samples considered as Test group. Extracorporeal shockwave will be applied to the Test samples. They will be further analysed using wound scratch assay which is used to assess Cell proliferative rate and scratch closure through live imaging. MTT assay and ATP assay used to determine Cell viability after exposure to shockwaves. The cell migration and cell viability after exposure to shockwaves will determine its effects on osteoblast-like cells.

Enrollment: 20 patients

Sex: All

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Cell cultures with a confluency of 70%-80%

Exclusion criteria

• Contaminated cell cultures

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

20 participants in 2 patient groups, including a placebo group

Shockwave treated group

Experimental group

Description:

The osteoblast like cells are treated with shockwaves

Treatment:

Device: Extracorporeal shockwave device

No shockwave group

Placebo Comparator group

Description:

The osteoblast like cells are not exposed to shockwaves

Treatment:

Device: No ESWT